Pharma Journalist 8786 posts 0 comments

Enable Injections announced it has entered into development agreements with Apellis Pharmaceuticals, and most recently, UCB. Enable Injections currently has partnerships with five…
Read More...

SMi’s RNA Therapeutics Conference 2019 is returning to London on the 20th & 21st February for its 10th year running. Despite the impressive strides recently being made in the…
Read More...

An exclusive interview with Dr Alexander Stoll, Vice President, Head of Competence Center Microbiology and Aseptic Techniques, Fresenius Kabi speaker at this year’s 8th Annual…
Read More...

SMi Group is proud to announce the return of Europe’s only Parallel Trade event conference, returning to Central London on 5th & 6th February 2019. The meeting will gather 90+…
Read More...

Aimmune Therapeutics announced that Nestlé Health Science will make an additional equity investment in Aimmune of $98 million, increasing Nestlé Health Science’s ownership of Aimmune to…
Read More...

Pain Therapeutics announced that it has petitioned the Food & Drug Administration (FDA) regarding a Complete Response Letter (CRL) for REMOXY issued August 2018.  The FDA and the…
Read More...

Metrics Contract Services (Metrics), a division of Mayne Pharma Group Limited, announced successful qualification of two commercial bottling lines for serialization at its new US$80…
Read More...

BridgeBio Pharma LLC and Cincinnati Children's Hospital Medical Center announced that they are entering into a research collaboration to identify and develop genetic disease therapies.…
Read More...

Ziopharm Oncology announced a clinical supply agreement with Regeneron Pharmaceuticals, Inc. to evaluate Ziopharm’s Ad-RTS-hIL-12 plus veledimex in combination with Regeneron’s PD-1…
Read More...

CRISPR Therapeutics and MaxCyte announced the expansion of their existing relationship by entering into a non-exclusive commercial license agreement that will allow CRISPR Therapeutics…
Read More...